Official 2024 U.S. DOL Form 5500 summary for Stemline Therapeutics, INC. (Stemline Therapeutics, INC. 401(k) Plan · EIN 45-0522567 · PN 001): $36.80M net assets, 358 active participants, and $3.14 per $10,000 (3.14 bps).
| Plan Sponsor | Stemline Therapeutics, INC. |
|---|---|
| Filing Identifier | Stemline Therapeutics, INC. 401(k) Plan · EIN 45-0522567 · PN 001 |
| Plan Category & State | 401(k) Defined Contribution (NY) |
| Asset-Size Peer Cohort | $25M-$100M |
| Plan Net Assets (2024) | $36.80M |
| Active Participants | 358 |
| Direct Admin Fee Rate | $3.14 per $10,000 (3.14 bps) |
| Cohort Peer Median | $19.23 per $10,000 (19.23 bps) |
| Primary Recordkeeper / Provider | Fidelity Investments |
| Schedule H Line 4a Remittance | Schedule H Line 4a Late Remittance Reported ($4,427, often administrative timing) |
Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI